![Biotech Bros artwork](https://is5-ssl.mzstatic.com/image/thumb/Podcasts113/v4/dc/eb/05/dceb052c-8d7c-0ceb-b0b5-b9876e612f77/mza_17634194225742257957.jpg/100x100bb.jpg)
Acquisitions in the $XBI, a Second Chance at bat for $AMLX, and a Potential Cure for Huntington's
Biotech Bros
English - July 18, 2022 12:00 - 57 minutes - 39.6 MBInvesting Business Health & Fitness Medicine biotech investing money finance get rich markets comedy health healthcare Homepage Download Google Podcasts Overcast Castro Pocket Casts RSS feed
This week on the podcast Agustin discusses the recent acquisition activity in the biotech space, some positive news for Amylyx Pharmaceuticals regarding a new chance to convince regulators of an approval at their second ad-board, and an incredible data readout for a new gene therapy targeting Huntington's Disease.
If you are a fan of this show make sure to like, comment, subscribe and follow me on Twitter @biotech_bros. If you have any questions regarding the product offerings feel free to explore my website biotechbros.com
Welcome to All Business. No Boundaries, a collection of supply chain stories by DHL...
Listen on: Apple Podcasts Spotify
If you are a fan of this show make sure to like, comment, subscribe and follow me on Twitter @biotech_bros. If you have any questions regarding the product offerings feel free to explore my website biotechbros.com